. . .We seem, in fact, to be witnessing a transition from katabolic to anabolic studies, made possible only by the use of the microbe as experimental material' (Stephenson, 1949) . Among the new sources responsible for this fresh stream of knowledge were studies of the intracellular changes resulting from chemotherapeutic agents, antibiotics and other cell poisons. We all know how crucial for the bacterial cell are the various steps by which the wall peptidoglycan precursors are synthesized in the cytoplasm and are assembled into a rigid, net-like polymer outside the plasma membrane. We also know how essential for the unravelling of the mechanisms involved was the use of D-CyClOSerine, bacitracin and penicillin.
The decision of the Society to pay tribute to Marjory Stephenson by organizing a lecture on the biosynthesis of the bacterial cell wall peptidoglycan and on the mode of action of penicillin, therefore seems to be most appropriate. However, as I stand before you on this occasion, I do so with mixed feelings. I am deeply honoured by the invitation but I am also convinced that friends who have much contributed to these problems, deserve this honour more than I do and would fulfil the duty in a more elegant way. Moreover, I have been fortunate in having extremely able colleagues : Milina Leyh-Bouille and Jacques Coyette who were with me from the start of our work; Jean-Marie Frkre, Jean Dusart and Martine Nguyen-Distkche who later joined us with fresh ideas; Harold R. Perkins now in Liverpool, Manuel Nieto now in Madrid, Peter E. Reynolds from Cambridge, and Jerry J. Pollock now in Stony Brook all played important, sometimes decisive roles in the work. I am sad that we cannot share this moment together. The Thirteenth Marjory Stephenson Memorial Lecture 15 penicilloyl-enzyme complex. Penicillin had a high selective toxicity because it was postulated to act on one enzyme which occurred solely in bacteria and because the initial driving force for the interaction was due to the presence in the enzyme of a penicillin-binding site which normally recognized a C-terminal D-Ala-D-Ala sequence, a structural feature completely missing in eukaryotic cells. Penicillin was very efficient because of the irreversible nature of the bond formed between the drug and the enzyme. Of the antimicrobial agents known, penicillin was the one which best fulfilled the canons of chemotherapy (at least if one does not take into account the allergic reactions associated with it and its destruction by penicillinase action). The hypothesis remains, but investigations carried out along different lines in various laboratories in the last 12 years do not substantiate it in all its details and the precise molecular mechanism by which p-lactams exert their lethal effect remains elusive.
The multiple enzymes concerned with the wall peptidoglycan crosslinking As early as 1966, it was known that the system involved in peptide crosslinking contained more than one single enzyme and that it consisted of at least two antagonistic activities (Araki et al., 1966; Izaki, Matsuhashi & Strominger, 1966) . In addition to the transpeptidase activity which catalyses peptide bond formation, bacteria also contain a DD-carboxypeptidase activity which simply hydrolyses the C-terminal D-Ala-D-Ala sequences of pentapeptide units without performing any transfer reaction (Fig. I) . As the transpeptidase is sensitive to penicillin, so too is the DD-carboxypeptidase activity. The idea immediately brought forward was that the DD-carboxypeptidase activity was there to limit the number of pentapeptide units made available to the transpeptidase activity and, therefore, to control the extent of peptidoglycan crosslinking. It was also suggested that the DD-carboxypeptidase might be an uncoupled transpeptidase. Roughly the idea was correct. Yet, it was far from expressing the real complexity of the problem.
The concept of a 'nascent peptidoglycan', which was rather vague in 1965, was rigorously substantiated thanks to the elegant studies of Ward & Perkins (1973) . In Bacillus licheniformis, chains consisting of multiple disaccharide-peptide units were shown to grow by addition of the new units at the reducing terminus of the lengthening chain. In the process, the reducing terminal N-acetylmuramic acid of the growing chain is transferred from its link with the membrane to the non-reducing N-acetylglucosamine terminus of the new disaccharide-peptide unit which is itself linked to the membrane (Fig. I) . The membrane acceptor on which the new disaccharide-peptide units are made is the undecaprenyl phosphate carrier. However, the membrane acceptor on which polymerization of the nascent peptidoglycan chains occurs has not yet been definitely characterized.
When growing in liquid suspensions, protoplasts excrete the soluble, nascent peptidoglycan they make and new walls cannot be formed. However, when incubated on the surface of an agar medium of low fluidity, protoplasts of B. lichenijiormis were shown to be able to revert successfully to normal rod-shaped bacilli (Elliott et dl., 1975a, b) . Hence, insolubilization of the peptidoglycan by peptide crosslinking between nascent strands can be carried out by cells which at the onset of the process completely lack pre-existing walls (Fig. I) . The same process probably takes place in normal, wall-containing cells. In this case, however, insolubilization of the nascent peptidoglycan is mainly achieved by attachment to the pre-existing wall peptidoglycan. Attachment of part of the precursor can be carried out by transglycosylation at the level of the glycan strands, a reaction which is not sensitive to penicillin (Mirelman, Bracha & Sharon, 1972 , but transpeptidation at the level of the peptide units appears to be the major mechanism involved. Two alternatives may exist: the nascent peptidoglycan may act as carboxyl donor through its C-terminal D-Ala-D-Ala sequences while the pre-existing wall peptidoglycan would act as amino acceptor; conversely, D-Ala-D-Ala sequences in the pre-existing wall peptidoglycan may function as donors, and amino groups of the newly synthesized peptidoglycan strands would (Fig. 2) and the second in Gafkya homari (Hammes, 1976; Hammes & Kandler, 1976) (Fig. 3) . This latter mechanism is especially complex. Indeed, those peptide units of the nascent peptidoglycan which serve as acceptor groups for transpeptidation are tetrapeptides resulting from prior DD-carboxypeptidase action. However, pentapeptide units must remain present in this nascent peptidoglycan in such a way that through the active transpeptidation of the tetrapeptide units, these pentapeptide units are passively incorporated into the wall peptidoglycan where they can serve as donor units for further expansion of the polymer. In vivo, the newly synthesized peptidoglycan strands which undergo attachment probably contain equimolar amounts of pentapeptide and tetrapeptide units. Such a ratio would allow a maximum degree of crosslinking of 50 % and oligomers larger than dimers could not be formed. In fact, such structural features are those found in the wall peptidoglycan of G. homari.
In parallel to the different mechanisms of wall peptidoglycan expansion, the specific inhibition of the DD-carboxypeptidase activity in B. subtilis and B. stearothermophilus does not cause detectable damage to the cell (Blumberg & Strominger, 1971; Yocum, Blumberg & Strominger, 1974) , suggesting that the transpeptidase is the enzyme that is physiologically important. On the contrary, the specific inhibition of the DD-carboxypeptidase activity in G. homari is sufficient to prevent peptidoglycan incorporation and to cause cessation of cell growth (Hammes, 1976) . Hence, a unified view on the nature of the enzyme on which penicillin binding causes cessation of cell growth (and cell lysis) cannot be proposed. The concept of a penicillin 'killing site' may well escape a precise definition.
In the Gram-negative bacteria and in various Gram-positive bacilli, the interpeptide bond made by transpeptidation is a D-Ala-(D)-meso-diaminopimelic acid linkage in cc position to a free carboxyl group (Fig. I) , a structural feature which fits well the substrate requirements for DD-carboxypeptidase action. Hence the extent of peptidoglycan crosslinking is susceptible to regulation not only by DD-carboxypeptidase action on the pentapeptide units before incorporation of the nascent peptidoglycan but also by DD-carboxypeptidase action on the interpeptide bonds in the completed peptidoglycan. DD-Carboxypeptidases which perform such endopeptidase activity exist ; they are also sensitive to penicillin (Bogdanovsky, Bricas & DezblCe, 1969) .
Septum formation in Escherichia coli has received much attention. A bold and attractive working hypothesis made by Mirelman, Yashow-Gan & Schwarz (1976) is that the nascent peptidoglycan would act as carboxyl donor for transpeptidation reactions with two types of acceptors. Reaction with the pre-existing wall peptidoglycan would lead to wall elongation, whereas reaction with a modified nascent peptidoglycan previously deprived of donor sites by DD-carboxypeptidase action and accumulated at the equator of the cell (i.e. where it is synthesized) would lead to septum formation. The specific inhibition of the DD-carboxypeptidase responsible for the destruction of the donor sites of the nascent peptidoglycan (and for its accumulation) and for the specific inhibition of the transpeptidase which uses this modified nascent polymer as amino acceptor would therefore prevent cell septation and would cause cell filamentation, a morphological damage which can be induced in E. coli cells by low levels of ampicillin. In fact, fractionation of the membrane-bound peptide crosslinking enzyme system of E. coli has shown that the DD-carboxypeptidase-transpeptidaseendopeptidase activities occur in two distinct forms, one of them being sensitive to low levels of ampicillin (and perhaps involved in cell septation) and the other being sensitive to much higher levels of ampicillin (and perhaps involved in cell elongation) (Pollock et al., 1974; Nguyen-Distkche et al., 1g74a, b) .
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--Membrane - The penicillin-binding components Tremendous efforts are being made in order to study the penicillin-binding components from penicillin-sensitive cells on the assumption that penicillin-sensitive enzymes and penicillin-binding proteins are synonymous. These studies, initiated in Professor Strorninger's laboratory, yielded important results (for a review, see Blumberg & Strominger, I 974). In agreement with the known complexity of the peptidoglycan crosslinking enzyme system, multiple penicillin-binding sites exist in both Gram-positive and Gram-negative bacteria. These binding sites occur in the plasma membrane and, to all appearances, they are distinct proteins. They can be detected by dodecylsulphate-polyacrylamide slab gel electrophoresis of membranes to which radioactive penicillin has been bound; they are numbered in the order of decreasing molecular weight. This technique has revealed the presence of at least six penicillin-binding proteins in E. coli, five in B. subtilis and B. rnegaterium, four in B. stearothermophilus and three in B. cereus.
Two complementary approaches have been taken. One, which has been more especially applied to E. coli, is to try to relate one or several of the penicillin-binding components to the various morphological responses that p-lactams can elicit in this organism: inhibition of cell septation and cell division; bulge formation ; formation of osmotically-stable ovoid cells; cessation of cell growth and cell lysis (Spratt, 1975 (Spratt, , 1977 . The six main penicillinbinding proteins in E. coli are minor components of the plasma membrane. If one assumes that one penicillin-binding site occurs per molecule, then one cell contains about 230 molecules of protein I (mol. wt 91 OOO), 20 of protein 2 (mol. wt 66000), 50 of protein 3 (mol. wt ~OOOO), I I O of protein 4 (rnol. wt ~~o o o ) , 1800 of protein 5 (mol. wt. 42000) and 570 of protein 6 (mol. wt 40000). Proteins 4, 5, and 6 are probably not involved in the effects on cell morphology produced by p-lactams. Protein 2 is required for the growth of E. coli as a rod-shaped cell and is the protein on which the amidinopenicillanic acids act to produce ovoid cells. Binding of p-lactams to protein 3 seems to cause inhibition of cell division and filamentation. Binding to both proteins 2 and 3 seems to cause bulge formation. Protein I would then be the site at which p-lactams bind to inhibit cell elongation, to cause cessation of cell growth and to induce cell lysis, i.e. protein I would be the 'main' transpeptidase. Protein I, however, may be two proteins, a situation which makes the problem more complex. Furthermore, in Salmonella typhimurium, protein 4, and not protein I , appears to have the greatest capacity for carrying out transpeptidation in vitro (Shepherd, Chase & Reynolds, 1977) . Finally, inhibition of cell elongation and cessation of growth may be caused by the inhibition of a penicillin-sensitive enzyme which cannot be detected as a penicillin-binding protein. Thus, for example, the penicillin-sensitive DD-carboxypeptidase IB of E. coli apparently cannot be detected by this technique (Tamura, Imae & Strominger, I 976). Hence, the penicillin-binding components detected by autoradiography of the slab gels do not necessarily reflect the complexity of the peptidoglycan crosslinking enzyme complex. Conversely, the efficiency of the binding largely depends upon the experimental conditions (antibiotic concentration, time of exposure etc.) and, under certain circumstances, penicillin may react non-specifically with proteins -in the sense that they are not members of the enzyme complex -which consequently are revealed as penicillin-binding components.
A second approach is to isolate and characterize the penicillin-binding components . Protein 5 of B. subtilis is a DD-carboxypeptidase. It was isolated by affinity chromatography on 6-aminopenicillanic acid-substituted Sepharose of solubilized membranes previously treated with cephalothin under conditions which allowed saturation of compounds I to 4 but not of compound 5. Protein 3 of B. stearothermophilus (Yocum et al., 1974) and proteins 5 and 6 of E. coli are also DD-carboxypeptidases (Spratt & Strominger, 1976) .
Obviously, the full significance of the penicillin-binding sites cannot be understood as 
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long as the relationship between them and the multiple penicillin-sensitive enzymes is not clearly established. One of the difficulties of the problem is the following. DD-Carboxypeptidase activity can be easily estimated by measuring the C-terminal D-Ala residue released from the relevant UDP-N-acetylmuramyl-pentapeptide precursors. Parallel to this, at least until recently, the penicillin-binding sites to which an enzyme activity could be assigned were DD-carboxypeptidases. The test for transpeptidase activity as it is performed in many laboratories makes use of various particular cell-free systems containing both the pre-formed wall peptidoglycan and all the enzymes involved in the synthetic pathway beyond the level of the nucleotide precursors. In the presence of the exogenously added nucleotides, the reaction proceeds through the complex series of steps and culminates in peptidoglycan crosslinking.
Of course, such an assay is of no value for testing a transpeptidase separated from the bacterial envelope and disconnected from the other enzymes which precede the transpeptidation reaction. The difficulty, however, can be overcome.
Exocellular enzymes from Streptomyces ~6 I and Actinomadura ~3 9 as models for the study of the peptidoglycan crosslinking enzyme system When a natural phenomenon is complex, it is useful to set up an artificial, well-defined model which mimics it as closely as possible. Such a model could be devised using enzymes from some actinomycetes, in particular Streptomyces R~I and Actinomadura ~3 9 . During growth these strains excrete exocellular enzymes able to catalyse reactions which resemble those catalysed in vivo by the corresponding crosslinking enzyme systems. Each of these enzymes consists of one single polypeptide chain with a molecular weight of 38000 for the R~I enzyme and 53000 for the R39 enzyme. Many of their physicochemical and enzymic properties are described in two recent reviews where details and a complete list of references can be found (Ghuysen, 1977; F r b e et al., 1976b) . Each of these enzymes performs three activities : a DD-carboxypeptidase activity, a transpeptidase activity and a penicillin-degrading activity. What, in summary, did we learn from them? DD-Carboxypeptidase-transpeptidase activity (I) Both enzymes catalyse hydrolysis reactions ; they are DD-carboxypeptidases. The C-terminal sequence giving the highest activity is D-Ala-D-Ala but the preceding L-amino acid residue also has a considerable effect on enzyme activity. Although differences exist between the two enzymes with regard to the influences of charged groups at the end of the side-chain of this L-amino acid residue, the synthetic tripeptide Ac2-L-Lys-D-Ala-D-Ala is an excellent substrate for each of them. The standard reaction is The transpeptidation reaction in Actinomadura ~3 9 occurs between
where the acceptor is the amino group located on a D-carbon (of meso-diaminopimelic acid) in a position to a free carboxyl group. The basic requirement of the R39 enzyme for an acceptor is precisely such a structural feature. Hence, the R39 enzyme is unable to catalyse transpeptidation reactions leading to the synthesis of peptide bonds in an endo-position and therefore it differs strikingly from the R~I enzyme. The standard reaction catalysed by the ~3 9 enzyme is
Whenever the enzyme performs transpeptidation, concomitant hydrolysis of the peptide donor also occurs. D-Ala is thus released by two pathways : by hydrolysis (DD-carboxypeptidase activity) and by transpeptidation (transpeptidase activity), the two processes competing with each other.
In aqueous media, at neutral pH and at low acceptor concentrations, both enzymes act mainly as DD-carboxypeptidases ; their transfer activities are low. However, the proportions of the catalytic activity that can be channelled into the hydrolysis and transpeptidation pathways, respectively, greatly depend upon the environmental conditions. Replacement of part of the water of the reaction mixture by solvents of low polarity preferentially decreases the DD-carboxypeptidase activity so that transpeptidation may largely supersede hydrolysis. Transpeptidation is also favoured by raising the pH value of the reaction mixture. The m-carboxypeptidase activity of the ~3 9 enzyme is little affected by the ionic strength but its transpeptidase activity is specifically enhanced at high ionic strength. The R~I enzyme, however, has maximal hydrolytic and transfer activities at low ionic strength. Finally, peptide acceptors behave as non-competitive inhibitors of the hydrolysis pathway and therefore high acceptor concentrations favour transpeptidation.
(4) With the ~3 9 enzyme and at low donor concentrations, hydrolysis is inhibited by increasing concentrations of acceptor to a greater extent than transpeptidation is increased. The acceptor is an inhibitor of the total enzyme activity. However, at high peptide donor concentrations when the donor site of the enzyme is saturated, the increase in the rate of the transfer reaction and the decrease in the rate of hydrolysis caused by increasing concentrations of acceptor (at least within certain limits) are commensurate. The enzyme activity that is diverted from the hydrolysis pathway because of the presence of the acceptor is channelled entirely into the transfer pathway. Under these conditions, the acceptor is an inhibitor of hydrolysis but not of the total enzyme activity which remains constant. Finally, another interesting feature of the system is that when complex peptide acceptors are used, not only hydrolysis but transpeptidation itself may be inhibited by excess acceptor.
(5) The effects that the concentrations of the donor and the acceptor, respectively, exert on the rates of transfer and hydrolysis reactions concomitantly catalysed by the R~I enzyme suggest that these reactions proceed through an ordered mechanism in which the acceptor binds first to the enzyme (A, acceptor; D, donor; E, enzyme):
The results obtained are not compatible with a mechanism where the donor binds first to the enzyme as in the Ping-Pong Bi Bi mechanism suggested by Tipper & Strominger (I 965). For complex peptide acceptors which at high concentrations inhibit the transpeptidation pathway, an additional acceptor binding site would be present on the enzyme leading to the formation of an (enzyme-acceptor2-donor) complex which would be non-productive for transpeptidation, and to the formation of an (enzyme-H20-acceptor-donor) complex remaining productive for hydrolysis. The above scheme would then b modified : Under these conditions, the rate of formation of the mono-amidated peptide dimer
is twofold higher than the rate of hydrolysis of the pentapeptide into During prolonged incubation, the released N-formyl-D-penicillamine undergoes spontaneous dimerization into di-(N-formyl-D-penicillamine) disulphide. The mechanism of the catalysis remains to be discovered. In particular, one should mention that fragmentation of benzylpenicillin by the DD-carboxypeptidase of B. sfearothermuphilus also yields phenylacetylglycine (Hammarstrom & Strominger, I 975). 5,5,-Dimethyl-A2-thiazoline carboxylic acid would be the other fragment (Hammarstrom & Strominger, 1976) . However, the fragment arising from the thiazolidine moiety of penicillin was almost certainly mischaracterized since under the conditions prevailing during the reaction (55 min; 55 "C; pH 6.5), 5,5-dimethyl-A2-thiazoline carboxylic acid has a half-life of 130 s and is transformed into N-formyl-D-penicillamine (J. M. Frkre, unpublished data). Under these conditions, the mechanism proposed for the enzymic fragmentation of penicillin on the assumption that 5,5-dimethyl-A2-thiazoline carboxylic acid was one of the primary products released remains entirely hypothetical.
concerns the nature of the degradation products. Benzylpenicillin is degraded into phenylacetylglycine and N-formyl-D-penicillamine with the formyl substituent arising from C5 of benzylpenicillin (Fig. 4) . When phenoxymethylpenicillin is used instead of benzylpenicillin, phenoxyacetylglycine and N-formql-~-penicillamine are produced. Hence the nature of the acyl substituent does not modify the pathway of the reaction. The overall reaction involves the addition of two H,O molecules and results in the hydrolysis of the amide bond and in the rupture of both C5-C6 and C5-S linkages. Enzyme reactivation and fragmentation of the penicillin molecule are concomitant events. However, N-formyl-D-penicillamine may not be the initial fragment arising from the thiazolidine moiety of the penicillin molecule but the nature of the possible intermediate remains to be determined. The products resulting from the interaction with cephalosporins have not yet been established. It is certain, however, that these antibiotics are also irreversibly destroyed during the reaction. h o t h e r peculiarity of the reaction is that it is a slow or a very slow process. Depending upon the enzymes and the P-lactams, the kcat values for the reactions range from 0.28 x I O -~ to 1-4 x I O -~ s-l (Table I) ( 2 ) The main feature of the reaction is that it proceeds through (i) the formation of a rather stable, stoicheiometric enzyme-P-lactam complex EI* in which the enzyme (E) is inactivated and the P-lactam (I, for inhibitor) is chemically modified, and (ii) the subsequent breakdown of complex EI* with regeneration of the enzyme and release of the antibiotic as biologically inactive metabolites k f o m t i o n kbreakdown
Formation of complex EI* is characterized by a second order rate constant (kforWtlon in M -~ s-l), and breakdown by a first order rate constant (kbreakdown in s-l). In some cases, at 37 "C at 37 "C
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Ampicillin-~3g Cephaloglycine-~3g The Thirteenth Marjory Stephenson Memorial Lecture 25 complex formation could be analysed by fast kinetics techniques. The simplest model which best explains the data is K k3 k, or E + I + E I h E I * ----+ E + degradation products Enzyme and p-lactam first react to form a complex EI (characterized by a dissociation constant K, in M) which, in turn, isomerizes into complex EI*. The isomerization step is characterized by a first order rate constant k3 (in s-l). Of course, k4 and kbredkdown are synonymous and the k,/K ratio (in M-I s-l) is equal to kfomation. Table I gives the kformation (with, in some cases, the individual K and k, values) and the kbreakdown values for various enzyme-/i'-lactam systems. The kbreakdown values have been converted into the half-lives of the complexes EI* : these range for 80 to 40000 min. The degradation of the complexes El* is thus the rate-limiting step and the kbreskdown values are equivalent to the kcat values for the overall reaction : antibiotic --+ degradation products.
(3) In the strict sense, one could claim that p-lactams are substrates of the R~I and ~3 9 enzymes. However, by immobilizing the enzymes in the form of inactive complexes El*, at least for some time, they also behave as inhibitors. The lower the K value, the higher the k, value (i.e. the higher the krormtion) and the higher the k4 value, the better is the antibiotic as a substrate. Conversely, the lower the K value, the higher the k, value (i.e. the higher the kformation) but the lower the k , value, the more active is the antibiotic as an inhibitor. At a low [I] value such that [I] < K , the important parameter is the kformation or k3/K value since the rate of formation of complex EI* directly depends on it. At a very low [I] value, the k, value is also very important since, at the steady state, the smaller its value, the higher is the proportion of the total enzyme that is immobilized in the form of complex EI*. The effectiveness of a p-lactam as an inhibitor can be expressed by the K, value, E which is equivalent to the Henri-Michaelis constant for the reaction p-lactam + degradation products. If, as is the case with the exocellular enzymes, k4 < k,, then Obviously, the lower the Kf value, the more active is the p-lactam as an inhibitor. The effectiveness of the inhibitor, however, is expressed more accurately by which gives the fraction of enzyme which remains functional at the steady state. Thus for [I] s-k4K/k, and at the steady state, all the enzyme is immobilized in the form of complex EI* irrespective of the absolute k4 value. At [I] = k4K/k3 if both k4 and k3 values are very small, then the formation of complex EI* may be so slow that within the duration of the experiment, it may not occur at all, i.e. the enzyme remains active.
(4) In no case is the recognition of the antibiotic by the enzyme, as expressed by the K value, exceedingly good (Table I) but there is a 20000-fold variation between the highest and the lowest k, values. Values of 180 and 13 s-l for the k3 constant are similar to the kcat value of a true enzymic reaction. Although slow, breakdown of the complexes EI* is enzymic at least in the sense that active groups in the enzyme and/or a proper configuration of the protein are involved in the process. Thus boiling of the complex EI* made between benzylpenicillin and the R~I enzyme stabilizes it (and makes it sensitive to pronase and thermolysine). Serine is the residue involved in penicillin binding to the ~6 1 enzyme (Fr6l-e et al., 1 9 7 6~) .
Another example is given by the ~3 9 enzyme. Breakdown of the complex formed between this latter enzyme and benzylpenicillin yields phenylacetylglycine (and probably N-formyl-D-penicillamine) when breakdown occurs in a medium of high ionic strength under which conditions the enzyme is reactivated. At low ionic strength (where the R39 enzyme is not stable), enzyme reactivation does not occur and breakdown of the complex yields benzylpenicilloic acid. Hence, under certain conditions, the enzyme behaves although with a low efficiency, as a classical penicillinase.
(5) It had been known for several years that the R39 enzyme was more sensitive to p-lactams than the R~I enzyme. Table I enzyme than with the R~I enzyme. Necessarily, the R~I enzyme is more resistant than the ~3 9 enzyme. The ktormation value, however, is the important parameter (at least under the conditions where the ID,, values were determined) as shown by the fact that for each antibiotic, the ratio of kformatjon (for the ~3 9 enzyme) to kformation (for the R~I enzyme) is very similar to the ratio of ID,, (for the R~I enzyme) to IDbo (for the ~3 9 enzyme) ( Table 2 ). (6) The differences between the R~I and ~3 9 enzymes with respect to their action on the p-lactams leads to a new concept of penicillin resistance. They show that alterations in the structure and/or the conformation of the enzymes that result in increased kbreakdom values (without altering the kformation value) or in decreased kformation values (without altering the kbr&dom value) lead to 'intrinsic resistance'. The comparison between the R~I and ~3 9 enzymes also provides an explanation for the large differences in penicillin sensitivity exhibited by the enzymes of the peptide crosslinking system.
(7) The concomitant interaction between enzyme, peptide donor Acz-L-Lys-D-Ala-o-Ala and p-lactam was studied both on the basis of the effect of the P-lactam on the rate of hydrolysis of the peptide donor and on the basis of the effect of the peptide donor on the rate of formation of complex EI*. Kinetically, the interaction was competitive but the conclusions were that it was not possible to decide whether or not binding of peptide donor and penicillin to the enzymes was mutually exclusive, and that a structural analogy between penicillin and peptide donor could not be justified on the basis of such experiments. It is clear that binding of penicillin to its site on the R~I and R39 enzymes with formation of the complexes EI* induces conformational changes in the enzymes. These changes might be sufficiently pronounced to freeze them in confcrmations that prevent both DD-carboxypeptidase and transpeptidase activities. Other techniques are being used in order to solve this important problem.
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The cell-bound peptidoglycan crosslinking enzyme system in Streptomyces R~I The exocellular R~I enzyme is 'lost' in the culture medium. The question therefore arises whether the model derived from the exocellular enzymes for the various reactions concerned with peptide donor, peptide acceptor and P-lactam applies to the physiological, cell-bound peptidoglycan crosslinking enzyme system.
The composition and functioning of the crosslinking enzyme system in Streptomyces are not yet fully understood. Recent progress has been made and I am indebted to Drs Mklina Leyh-Bouille, Martine Nguyen-Distcche and J. Dusart, and to Dr P. E. Reynolds from the University of Cambridge, for results that have not yet been published elsewhere. What do we know of the system? (I) The tripeptide Ac,-~-Lys-~-Ala-~-Ala is both hydrolysed and utilized in a transfer reaction with Gly-Gly by at least two types of cell-bound enzyme activities. The two activities are located in distinct parts of the cell envelope and are antagonists in the sense that one of them acts mainly as a DD-carboxypeptidase and is highly sensitive to penicillin whereas the other acts mainly as a transpeptidase and has a low sensitivity to penicillin.
(2) The enzyme which acts mainly as a DD-carboxypeptidase (with a low transpeptidase activity, at least in water, at neutral pH and at low acceptor concentrations) and has a high sensitivity to penicillin is released from the mycelium during transformation into protoplasts in sucrose medium (unpublished data). This lysozyme-releasable enzyme is very similar, perhaps identical, to the exocellular enzyme : the proportion of total activity that is channelled into hydrolysis and transfer depends upon the environmental conditions; the enzyme utilizes the tetrapeptide Ac-L-Lys-D-Ala-D-Ala with formation of peptide dimer ; when treated with [14C]benzylpenicillin and submitted to SDS slab gel electrophoresis, it migrates exactly as the exocellular enzyme ; finally, its activities are inhibited by antibodies prepared against the exocellular enzyme. Its exact localization in the cell is not known, but the comparison between the levels of exocellular and lysozyme-releasable enzymes among various streptomycetes suggests that a correlation exists between the amount of enzyme that is excreted in the medium and the amount of lysozyme-releasable enzyme present in the mycelium. Streptomyces rimosus, for example, contains extremely low levels of lysozymereleasable enzyme and excretes only traces of exocellular enzyme.
(3) The enzyme which acts mainly as a transpeptidase (with a low DD-carboxypeptidase activity) and has a low sensitivity to penicillin is firmly associated with the plasma membrane. Gly-Gly, various peptides possessing an N-terminal glycine residue and other amino compounds are utilized by the isolated membranes for transpeptidation reactions with Ac,-L-Lys-D-Ala-D-Ala as donor. Qualitatively, the specificity profile of the membranebound enzyme fits well the requirements for amino acceptor exhibited by the exocellular enzyme (Dusart et al., 1973) . There is an exception, however: Ac-L-Lys-D-Ala-D-Ala is not utilized as substrate by the isolated membranes (unpublished data). The kinetics of the membrane-catalysed transpeptidation between Ac,-~-Lys-~-Ala-~-Ala and Gly-Gly fit the general initial rate equation for an enzyme-catalysed bimolecular reaction listed above can be found in Marquet et al. (1974) .
in a solid, frozen state. A temperature as low as -30 "C is required to prevent the enzyme from catalysing the reaction, suggesting that the enzyme functions in a lipid environment that remains remarkably fluid at low temperature (Dusart et al., 1975) . (4) The isolated membranes fix in a rather stable manner about 25 pmol [14C]benxylpenicillin per mg protein, under which conditions the transpeptidase activity is totally inhibited (Marquet et ul., 1974) . The interaction between the membrane transpeptidase and p-lactams fits the general scheme (Marquet et al., 1974) kformation kbreakdown
During breakdown, the transpeptidase is reactivated and recovers its initial ability to react with penicillin. With [14C]benzylpenicillin, release of the radioactivity and enzyme recovery proceed with the same kbreakdom value of 1.1 x 1 0~~ s-' (indicating a half-life value of 104 min) (Marquet et al., 1974) . A major part of the released radioactivity occurs in the form of
[14C]benzylpenicilloic acid (about 75 %) and a minor part of it in the form of another metabolite X (about 25 %; unpublished data). Hence, it seems safe to conclude that (i) the transpeptidase in the membrane reacts with p-lactams according to the model proposed for the exocellular enzyme, (ii) it functions as a penicillinase with 'a low kcat value and (iii) at least most of the penicillin-binding sites on the membrane are the transpeptidase molecules.
(5) Table 3 gives the kfomtion and kbreakdom values for the interaction between p-lactams and the membrane-bound transpeptidase (unpublished data). These determinations were possible because the isolated membranes of Streptomyces R~I do not possess any classical' penicillinase activity. Penicillinase activity would degrade penicillin into penicillaic acid at a much faster rate than transpeptidase activity is regenerated through breakdown of complex EL*. In fact, membrane-bound and exocellular penicillinase activities occur in many streptomycetes other than strain ~6 1 . On the basis of the Ki values of Tables I and   3 , the membrane-bound transpeptidase is less sensitive to P-lactams than the exocellular enzyme. Thus the Ki values for benzylpenicillin are 10 n M with the exocellular enzyme and 2-2 p~ with the membrane-bound enzyme. With all the P-lactams tested, except for ampicillin, the kfomtion is always higher with the exocellular enzyme than with the membranebound enzyme (Tables I and 3) .
(6) The data of Table 3 also show that the effectiveness of p-lactams is very similar with regard to their ability to inhibit the membrane-bound transpeptidase (K, and ID,, values), to bind to isolated membranes (as shown by competition; Excl . D5, values) and to inhibit the formation of single cell colonies from conidia on agar nutrient plates (LD50 values). Hence one (or the) enzyme which has to be inactivated in order to prevent the early develop-
The Thirteenth ment of the mycelium from the spores appears to be the membrane-bound transpeptidase. It may be that the lysozyme-releasable enzyme is not present at that early stage of cell growth. If present, then, because of its high penicillin sensitivity, it may simply immobilize a certain amount of p-lactam (detoxication effect). The present results, however, do not exclude the possibility that the lysozyme-releasable enzyme is, in turn, physiologically important at later stages of the mycelial growth. This question is currently under investigation.
(7) Antibodies specific for the R~I exocellular enzyme do not bind to the isolated membranes and have no effects on its transpeptidase activity (unpublished data). The enzyme might be buried too deeply within the lipid phase of the membrane to be accessible. However, analysis on SDS slab gels of the membranes previously charged with radioactive benzylpenicillin reveals two to three penicillin-binding components of molecular weight of about 20000 to 25 000, in addition to another penicillin-binding component of molecular weight of about 50 000 (unpublished data). These components have molecular weights that are either considerably lower or higher than the molecular weights of the lysozyme-releasable and exocellular enzymes. Extraction of the membranes (or of the washed mycelium) with the cationic detergent N-cetyl-N,N,N-trimethylammonium bromide, folIowed by fiftration on Sephadex G-100, yields a soluble preparation (Dusart et al., 1975) enriched in enzyme activity. The enzyme thus solubilized remains a transpeptidase with low DD-carboxypeptidase activity but its properties are somewhat altered with the results that (i) it has a better fit for the two synthetic substrates Ac,-L-Lys-D-Ala-D-Ala and Gly-Gly (as revealed by the QD and @A values), (ii) both the kfomtion and kbreakdown values for the interactions with p-lactams are modified and (iii) [14C] benzylpenicillin is now fragmented with formation of [14C]phenylacetylglycine as observed with the exocellular enzyme (unpublished data).
(8) The relationship between the membrane-bound transpeptidase and both the lysozymereleasable and exocellular enzymes in Streptomyces ~6 I is still rather mysterious. However, an interesting observation was made with Streptornyces K I~ (unpublished data). Like strain ~6 1 , Streptomyces K I 5 excretes an exocellular DD-carboxypeptidase, contains a lysozyme-releasable DD-carboxypeptidase and has a transpeptidase fixed on its membrane. The two former enzymes -but not the membrane-bound transpeptidase -are sensitive to the anti-exocellular R~I enzyme antibodies. Streptomyces K I 5, in addition, possesses on its membrane a DD-carboxypeptidase able to perform low transpeptidase activity. This membrane-bound DD-carboxypeptidase which is hardly detectable in Streptomyces ~6 I, has, in Streptomyces ~1 5 , the following properties: (i) it is inhibited by the anti-exocellular R~I enzyme antibodies; (ii) after extraction with the cationic detergent and on the basis of its elution pattern on Sephadex G-100, it has a molecular weight higher than that of the membrane-bound transpeptidase; and (iii) it enables the isolated membranes to react with Ac-L-Lys-D-Ala-D-Ala. It is therefore tempting to postulate that in Streptomyces K I 5, the membrane-bound DD-carboxypeptidase is at the branching point of two distinct pathways : one leading via the lysozyme-releasable enzyme to enzyme excretion, and the other leading somehow to a membrane-bound transpeptidase in the form of iso-enzymes responsible for the presence of multiple penicillin-binding sites in the membrane. One may also postulate that the same situation occurs in all streptomycetes but that, depending upon the strain and/or the stage during cell growth, great variations in the amounts of enzymes present may occur with the result that some of them may be beyond the limits of detection. The membrane-bound transpeptidase, however, is always detectable. Half-life of Growth kformstion kbrwkdown complex EI" inhibition at 37 "C at 37 "C at 37 "C in m.i.c. 
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The membrane-bound Dmcarboxypep t idase in Strep tococcus faecalis
ATCC9790 as the target of ,8-lactams
Bacteria, more conventional as sources of biochemical material than streptomycetes, were also investigated. Streptococcus faecalis provides another example where a relationship exists between the effects of P-lactams on bacterial growth and their activity in vitro upon one defined cell-bound enzyme. In the present case, the enzyme is a membrane-bound DD-carboxypeptidase active on Ac,-L-Lys-D-Ala-D-Ala and able to catalyse exchange reactions with simple amino compounds such as D-Ala, Gly and Gly-Gly (Coyette et al., I 974, 1977~2, b) . The isolated membranes of Streptococcus faecaZis contain six penicillinbinding proteins which altogether fix about IOO pmol benzylpenicillin per mg protein (R. Fontana, unpublished data). The DD-carboxypeptidase is protein 6 and it represents about one-third of all the binding sites. The kfonnation and kbreakdown values for the interaction between the membrane-bound DD-carboxypeptidase and p-lactams are given in Table 4 . Interaction with benzylpenicillin yields phenylacetylglycine and N-formyl-D-penicillamine. Fragmentation is prevented by heating the membrane-penicillin complex at IOO "C. All the complexes tested have half-lives which are equal to or longer than the generation time of the organism (30 min). Finally, the relative effectiveness of the P-lactams in vivo rests
The Thirteenth Marjory Stephenson Memorial Lecture 31 almost entirely upon the kformation values: as shown by the data of Table 4 and Fig. 5 , the higher the kfomation value the lower is the minimum inhibitory concentration (m.i.c.) of the corresponding P-lactam. Thus, in Streptococcus jaecalis, normal functioning of the membrane-bound DD-carboxypeptidase enzyme may be important if not necessary for cell growth.
The DD-carboxypeptidase of the unstable spheroplast of Proteus mirabilis Mention should be made of enzymes which may well form ternary complexes with peptide donor and P-lactam. One of them is the membrane-bound DD-carboxypeptidase isolated from spheroplasts of the unstable L-form of Proteus mirabilis strain 19 (Martin, Maskos & Burger, 1975; Martin, Schilf & Maskos, 1976; Schilf et al., 1977) . Its interaction with benzylpenicillin is characterized by a kf,rm:Lt,on of about 4000 M -~ s-l (W. Schilf & J-M. Fr&re, unpublished data) and a khreakdown of about 3-3 x I O -~ s-l, i.e. a half-life of about 3 min (at 37 "C). Benzylpenicilloic acid is released. Of course, such a rapid breakdown confers a high penicillin resistance to the enzyme. The Proteus bacterial form possesses the equivalent of the L-form DD-carboxypeptidase and, in addition, a second DD-carboxypeptidase characterized by amuch higher penicillin sensitivity and a half-life of several hours for the complex EI* with benzylpenicillin (H. H. Martin, personal communication). Protein 5 of E. coli (Spratt, 1977) and protein 5 of Salmonella typhimurium (Shepherd et al., 1977) are other examples of enzymes forming complexes EI* with benzylpenicillin which have very short half-lives (5 min).
Another interesting feature of the Proteus L-form enzyme is that, kinetically, it is inhibited by penicillin in a non-competitive manner. Competitive kinetics are never persuasive because a ternary complex may be formed only at higher concentrations of either the substrate or penicillin than those which are, or can be, used. Conversely, non-competitive kinetics indicate with some weight that binding of donor substrate and binding of penicillin occur on at least partially independent sites on the enzyme.
Conclusions
The use of artificial substrates in uncoupled transpeptidation assays can probably be extended to all bacteria. At present, its application has been limited, presumably because it is difficult to design a proper system of donor and acceptor. However, dimerization of the pentapeptide L-Ala-D-Glu is achieved not only by the i(L)-meso-A,pm-( L)-D-Ala-D-Ala exocellular enzyme of Actinomadura R39, but also by various membrane-bound transpeptidases, such as those of E. coli 1g74a, b) and Salmonella typhimurium (Shepherd et al., 1977) . In fact, the penicillin-binding proteins r, 4 and 5 of Salmonella typhimzirium are DD-carboxypeptidases-transpeptidases able to catalyse dimer formation (Shepherd et al., 1977) . That the same reaction can be catalysed by enzymes originating from organisms taxonomically very different is not surprising when the wall peptidoglycans in these organisms have the same primary structure.
There are reports in the literature where enzymes are designated as transpeptidases on the basis of their ability to replace the C-terminal D-Ala residue of a peptide donor by Gly or a simple D-amino acid residue. Such an exchange reaction does not prove the occurrence in the enzyme of an 'acceptor site' concerned with peptide dimerization. This lack of accuracy in the terminology is unfortunate since it adds confusion to the picture.
The present review has been necessarily limited to selected topics. However, from an integration of these and other studies, it has become certain that the mode of action initially proposed for penicillin in order to explain its effect on the exocellular R~I and ~3 9 enzymes is general. Quantitatively, the constants involved vary considerably depending upon the enzymes and their bacterial origin and, qualitatively, there is more than one possible pathway for the enzymic degradation or fragmentation of the antibiotic molecule. The concept of chemotherapy, which stems back to the discovery of Prontosil in 1935, was firmly established by the first cures achieved by penicillin in 1941. A second penicillin era, which we are still living in, started in 1957 when it was learnt that semi-synthetic penicillins with increased penicillinase resistance could be made by adding side-chains to the 6-aminopenicillanic acid nucleus. This revolution was 'to open the possibility of chemotherapy being able to adapt itself by producing new products to meet the adaptations nature produces in the micro-organisms' (Wilson, 1976) . One day, the peptidoglycan crosslinking enzyme system may be so precisely known that specific inhibitors will be built on a rational basis and used as new antibacterial agents. It is difficult to predict when biochemists will open this third revolution. It is certain that the problem is being fiercely attacked from several quarters.
